Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024)
Opko Health's (OPK) quarterly Non-Current Deffered Revenue came in at $7000.0 in Q3 2024, down 94.85% on a YoY basis from $136000.0 in Q4 2023, and little changed quarter-over-quarter from $7000.0 in Q2 2024.
Opko Health (OPK) Non-Current Deffered Revenue (2022 - 2024) Analysis & Trends
Opko Health (OPK) has reported Non-Current Deffered Revenue for 3 consecutive years, with $7000.0 the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Deffered Revenue fell 94.85% year-over-year to $7000.0; the trailing twelve-month figure through Sep 2024 stood at $7000.0 (down 94.85% YoY), and the FY2024 full-year result was $7000.0, changed N/A from the prior year.
- Non-Current Deffered Revenue was little changed at $7000.0 in Q3 2024 per OPK's latest filing, from $7000.0 in the prior quarter.
- Across five years, Non-Current Deffered Revenue topped out at $140000.0 in Q2 2023 and bottomed at $7000.0 in Q4 2023.
- Historically, Non-Current Deffered Revenue has averaged $63142.9 across 3 years, with a median of $7000.0 in 2023.
- The widest YoY moves for Non-Current Deffered Revenue: up 94.85% in 2024, down 95.0% in 2024.
- Over 3 years, Non-Current Deffered Revenue stood at $138000.0 in 2022, then plunged by 94.93% to $7000.0 in 2023, then changed by 0.0% to $7000.0 in 2024.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $7000.0, $7000.0, and $7000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | - |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | - |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | - |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | - |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | - |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | - |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | - |
| 10 | Opko Health | 1.25 Bn | 945.61 Mn | 80.02 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 136,000.00 |
| Jun 30, 2023 | 140,000.00 |
| Dec 31, 2022 | 138,000.00 |
Opko Health Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "OPK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=OPK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();